Connect
MJA
MJA

Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older

Peter J Collignon
Med J Aust 2014; 201 (4): 199-200. || doi: 10.5694/mja14.00272
Published online: 18 August 2014

To the Editor: Menzies and colleagues promote the 23-valent polysaccharide pneumococcal vaccine (23vPPV) as effective in people aged 65 years or older.1 I believe their data show exactly the opposite. The vaccine appears to be ineffective.

  • Peter J Collignon

  • Medical School, Australian National University, Canberra, ACT.


Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.